Teva Pharmaceutical Industries Ltd.

Regulatory Filings • Apr 20, 2018

Filing Activity Result

job/cycle: 558803 / 13 LIVE FILING page 1 of 1

Subject: ACCEPTED FORM TYPE 424B3 (0001193125-18-122692)
Date: 19-Apr-2018 16:31
THE FOLLOWING SUBMISSION HAS BEEN ACCEPTED BY THE U.S. SECURITIES AND EXCHANGE
COMMISSION.
COMPANY: TEVA PHARMACEUTICAL INDUSTRIES LTD
FORM TYPE: 424B3 NUMBER OF DOCUMENTS: 4
RECEIVED DATE: 19-Apr-2018 16:30 ACCEPTED DATE: 19-Apr-2018 16:31
FILING DATE: 19-Apr-2018 16:30
TEST FILING: NO CONFIRMING COPY: NO
ACCESSION NUMBER: 0001193125-18-122692
FILE NUMBER(S):
 1. 333-224102
THE PASSWORD FOR LOGIN CIK 0001193125 WILL EXPIRE 01-Feb-2019 18:17.
PLEASE REFER TO THE ACCESSION NUMBER LISTED ABOVE FOR FUTURE INQUIRIES.
REGISTRANT(S):
 1. CIK: 0000818686
 COMPANY: TEVA PHARMACEUTICAL INDUSTRIES LTD
 FORM TYPE: 424B3
 FILE NUMBER(S):
 1. 333-224102
 2. CIK: 0001628587
 COMPANY: Teva Pharmaceutical Finance Netherlands II B.V.
 FORM TYPE: 424B3
 FILE NUMBER(S):
 1. 333-224102-02
 3. CIK: 0001679183
 COMPANY: Teva Pharmaceutical Finance Netherlands III B.V.
 FORM TYPE: 424B3
 FILE NUMBER(S):
 1. 333-224102-01